IP Verse

Neisserial Antigenic Peptides

Patent No. EP1801219 (titled "Neisserial Antigenic Peptides") was filed by GlaxoSmithKline Biologicals SA on Oct 30, 2000. The application was issued on Oct 14, 2015.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
PFIZERJul 14, 2016DORRIES

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP1801219

GLAXOSMITHKLINE BIOLOGICALS SA
Application Number
EP07075161A
Filing Date
Oct 30, 2000
Status
Revoked
Apr 15, 2019
Publication Date
Oct 14, 2015
External Links
Slate, Register , Google Patents